Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
The author of the article would like to add a video abstract as a supplementary material for a published article. The supplementary file is published with this correction. …
Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
Auteurs
Véronique Crutel
Estelle Lambert
Pierre-François Penelaud
Cristina Albarrán Severo
Joaquin Fuentes
Antoine Rosier
Amaia Hervás
Stéphane Marret
Guiomar Oliveira
Mara Parellada
Simon Kyaga
Sylvie Gouttefangeas
Marianne Bertrand
Denis Ravel
Bruno Falissard